Vaccinations in rheumatic diseases

Código QR

Vaccinations in rheumatic diseases

Guardado en:

Detalles Bibliográficos
Autores principales:	Martyna Szwejkowska, Ernest Kuchar
Formato:	article
Lenguaje:	EN
Publicado:	Termedia Publishing House 2020
Materias:	Medicine R
Acceso en línea:	https://doaj.org/article/aa88b93f0af146beaef6615628ee15a8
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Update on COVID-19 vaccines and autoimmune-mediated rheumatic diseases
por: Lakshmanan Suresh
Publicado: (2021)

Liver involvement in rheumatic diseases
por: Joanna Podgórska, et al.
Publicado: (2020)

Rheumatic Fever & Rheumatic Heart Disease

COVID-19 – rheumatic diseases and rheumatologists
por: Maria Maślińska
Publicado: (2021)

Polygenic risk scores and rheumatic diseases
por: Matthew A. Brown, et al.
Publicado: (2021)

Health related quality of life among Rheumatic Fever and Rheumatic Heart Disease patients in India.
por: Jyoti Dixit, et al.
Publicado: (2021)

Health related quality of life among Rheumatic Fever and Rheumatic Heart Disease patients in India
por: Jyoti Dixit, et al.
Publicado: (2021)

Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
por: Jasvinder A Singh, et al.
Publicado: (2021)

Features of heritable disorders of connective tissue in children with acute rheumatic fever and rheumatic heart disease
por: Oksana Boyarchuk
Publicado: (2020)

The macrophages in rheumatic diseases
por: Laria A, et al.
Publicado: (2016)

Meta-Analysis of Asymmetric Dimethylarginine Concentrations in Rheumatic Diseases
por: Gian Luca Erre, et al.
Publicado: (2019)

Clinical manifestations of Whipple’s disease mimicking rheumatic disorders
por: Eugeniusz J. Kucharz, et al.
Publicado: (2021)

Editorial: Osteoporosis in Rheumatic Diseases, What's New?
por: Barbara Ruaro, et al.
Publicado: (2021)

Differential diagnostic value of rheumatic symptoms in patients with Whipple’s disease
por: Gerhard E. Feurle, et al.
Publicado: (2021)

Anti-angiogenic effects of biotechnological therapies in rheumatic diseases
por: Cantatore FP, et al.
Publicado: (2017)

International journal of rheumatic diseases

Clinical application of mesenchymal stem cells in rheumatic diseases
por: Yajing Wang, et al.
Publicado: (2021)

Gut Microbiota–Medication Interaction in Rheumatic Diseases
por: Lingshu Zhang, et al.
Publicado: (2021)

Romatizma/Rheumatism

Socioeconomic and environmental risk factors among rheumatic heart disease patients in Uganda.
por: Emmy Okello, et al.
Publicado: (2012)

Association of Parvovirus B19 with Rheumatic Diseases
por: Chi Kit Au, et al.
Publicado: (2021)

COMPLEXITY OF EARLY DIAGNOSIS AND TREATMENT OF RHEUMATIC DISEASES
por: M. V. Sklyanova, et al.
Publicado: (2012)

Rheumatic heart disease in pregnancy and neonatal outcomes: A systematic review and meta-analysis.
por: Joshua Liaw, et al.
Publicado: (2021)

The Relationship between Hematological Indices and Autoimmune Rheumatic Diseases (ARDs), a Meta-Analysis
por: Xuanyu Hao, et al.
Publicado: (2017)

Strategies for prevention and control of rheumatic fever and rheumatic heart disease in Sub-Saharan Africa: a preliminary cost-effectiveness analysis
por: D. Watkins, et al.
Publicado: (2015)

Rheumatic Manifestations and Diseases From Immune Checkpoint Inhibitors in Cancer Immunotherapy
por: Pan Shen, et al.
Publicado: (2021)

Vitamin D supply in patients with rheumatic diseases in Poland. A pilot study
por: Marta Runowska, et al.
Publicado: (2021)

Clinical significance of monitoring hypothyroidism in patients with autoimmune rheumatic disease: a retrospective cohort study
por: Sho Fukui, et al.
Publicado: (2021)

Changes in the use patterns of bDMARDs in patients with rheumatic diseases over the past 13 years
por: Carlos Sánchez-Piedra, et al.
Publicado: (2021)

Arthritis and rheumatism

The Importance of Outcome Measures in the Management of Inflammatory Rheumatic Diseases
por: Molina Collada J, et al.
Publicado: (2021)

Long-term use of adalimumab in the treatment of rheumatic diseases
por: Charalampos Papagoras, et al.
Publicado: (2009)

Should we be Afraid of Immune Check Point Inhibitors in Cancer Patients with Pre-Existing Rheumatic Diseases? Immunotherapy in Pre-Existing Rheumatic Diseases
por: Kalliopi Klavdianou, et al.
Publicado: (2021)

Prognostic value of hypoalbuminemia for adverse outcomes in patients with rheumatic heart disease undergoing valve replacement surgery
por: Xue-biao Wei, et al.
Publicado: (2017)

IL-6 amplifies TLR mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases.
por: Ivan Caiello, et al.
Publicado: (2014)

The relationship between plasma proadrenomedullin level and severity of the disease in patients with isolated rheumatic mitral stenosis
por: Ali Rıza Demir, et al.
Publicado: (2021)

Potential adverse health consequences of climate change related to rheumatic diseases
por: Thomas Bush
Publicado: (2021)

Correlation between HLA haplotypes and the development of antidrug antibodies in a cohort of patients with rheumatic diseases
por: Benucci M, et al.
Publicado: (2018)

The challenge of screening for asymptomatic rheumatic heart disease in South Africa
por: Liesl Zühlke, et al.
Publicado: (2017)

Randomised controlled trial into the role of ramipril in fibrosis reduction in rheumatic heart disease: the RamiRHeD trial protocol
por: Ade Meidian Ambari, et al.
Publicado: (2021)